Outlook - Can open-source R&D reinvigorate drug research?

被引：70
|
作者：
Munos, Bernard [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
来源：
NATURE REVIEWS DRUG DISCOVERY | 2006年 / 5卷 / 09期
基金：
英国惠康基金; 美国国家卫生研究院;
关键词：
D O I：
10.1038/nrd2131
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?
引用
收藏
页码：723 / 729
页数：7
相关论文
共 50 条
  • [1] Can open-source R&D reinvigorate drug research?
    Bernard Munos
    [J]. Nature Reviews Drug Discovery, 2006, 5 : 723 - 729
  • [2] Can Open-Source Drug R&D Repower Pharmaceutical Innovation?
    Munos, B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (05) : 534 - 536
  • [3] Can open-source drug development deliver?
    Anderson, Tatum
    [J]. LANCET, 2016, 387 (10032): : 1983 - 1984
  • [4] R&D crisis in drug discovery for neglected diseases: scope for an open source approach to pharmaceutical research
    Thiruthy, Narendran
    [J]. JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE, 2016, 11 (08) : 599 - 611
  • [5] China Spallation Neutron Source: Design, R&D, and outlook
    Wei, Jie
    Chen, Hesheng
    Chen, Yanwei
    Chen, Yuanbo
    Chi, Yunlong
    Deng, Changdong
    Dong, Haiyi
    Dong, Lan
    Fang, Shouxian
    Feng, Ji
    Fu, Shinian
    He, Lunhua
    He, Wei
    Heng, Yuekun
    Huang, Kaixi
    Jia, Xuejun
    Kang, Wen
    Kong, Xiangcheng
    Li, Jian
    Liang, Tianjiao
    Lin, Guoping
    Liu, Zhenan
    Ouyang, Huafu
    Qin, Qing
    Qua, Huamin
    Shi, Caitu
    Sun, Hong
    Tang, Jingyu
    Tao, Juzhou
    Wang, Chunhong
    Wang, Fangwei
    Wang, Dingsheng
    Wang, Qingbin
    Wang, Sheng
    Wei, Tao
    Xi, Jiwei
    Xu, Taoguang
    Xu, Zhongxiong
    Yin, Wen
    Yin, Xuejun
    Zhang, Jing
    Zhang, Zong
    Zhang, Zonghua
    Zhou, Min
    Zhu, Tao
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2009, 600 (01): : 10 - 13
  • [6] Defense R&D and national R&D systems: a European outlook
    Daffix, Sylvain
    Jacquin, Yves
    [J]. ECONOMICS OF PEACE AND SECURITY JOURNAL, 2009, 4 (01): : 14 - +
  • [7] Engineering R&D trails drug research
    不详
    [J]. IEE REVIEW, 2004, 50 (11): : 20 - 20
  • [8] Major drug firms open R&D centers
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 2000, 78 (27) : 9 - 9
  • [9] Mixed R&D outlook for industry
    Rovner, Sophie
    [J]. CHEMICAL & ENGINEERING NEWS, 2007, 85 (13) : 38 - 38
  • [10] Open source software and R&D competition in software industries
    Xing, Mingqing
    [J]. CEIS 2011, 2011, 15
12345